Imaging in Semaglutide Study
Conditions : Type 2 Diabetes; BMI Greater Than 30 Interventions : Radiation: 31P-MRS and MRI Sponsors : The Cleveland Clinic Not yet recruiting
Read the full articleYou might also wanna read

Semaglutide Shows Chondroprotective Effects in Osteoarthritis Through Weight Loss-Independent Metabolic Mechanism
Qin et al. demonstrated the chondroprotective effects of semaglutide in obesity-related osteoarthritis. Mechanistically, these effects are i
Study: GLP-1 drugs like semaglutide linked to lower amputation risk in diabetes patients with peripheral artery disease
A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type 2 diabetes and
medicalnewstoday.com·7d ago
ADA 2026: New GLP-1 Oral Drug, Semaglutide-Amylin Combo, and Chinese Mazdutide Data Highlighted
This Medical News article is an interview with Rita Kalyani, MD, MHS, the American Diabetes Association’s chief scientific and medical offic
Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy
Semaglutide slows epigenetic aging in HIV-associated lipohypertrophy. In a 32-week trial, 45 on semaglutide vs. 39 on placebo showed promisi

REIMAGINE trials demonstrate efficacy of combination therapy for treating type 2 diabetes
Donna Ryan, MD, and other panelists reported on new data from phase 3 trials evaluating the combination of cagrilintide, which mimics amylin
ADA 2026 Scientific Sessions: New GLP-1 Drugs and Diabetes Research Highlights
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity resea

Comments
Sign in to join the conversation.
No comments yet. Be the first.